First Light Asset Management, LLC
- SEC CIK
- 0001600004
- Latest filing
- Aug 14, 2026
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 12, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 83
- +4 vs. Q2 2021
- Portfolio value
- $1.52B
- −$149.1M (−8.9%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PRTAProthena Corp Public Ltd Co | SHS | 1,449,494 | $103.2M | 6.8% | −478,335−24.8% | Reduced | History |
| SPNESeaSpine Holdings Corp | COM | 6,263,260 | $98.5M | 6.5% | +274,751+4.6% | Added | History |
| MODNModel N, Inc. | COM | 2,478,532 | $83.0M | 5.5% | +316,596+14.6% | Added | History |
| HALOHalozyme Therapeutics, Inc. | COM | 1,477,496 | $60.1M | 4.0% | −572,777−27.9% | Reduced | History |
| XENTIntersect ENT, Inc. | COM | 2,136,823 | $58.1M | 3.8% | −74,147−3.4% | Reduced | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 479,186 | $57.2M | 3.8% | −49,420−9.3% | Reduced | History |
| CDNACareDx, Inc. | COM | 900,470 | $57.1M | 3.8% | +4,213+0.5% | Added | History |
| OMCLOmnicell, Inc. | COM | 354,042 | $52.5M | 3.5% | −27,103−7.1% | Reduced | History |
| NEONeogenomics Inc | COM NEW | 1,055,960 | $50.9M | 3.4% | −92,985−8.1% | Reduced | History |
| ATRCAtriCure, Inc. | COM | 647,192 | $45.0M | 3.0% | −125,583−16.3% | Reduced | History |
| OPRXOptimizeRx Corp | COM NEW | 507,384 | $43.4M | 2.9% | −157,458−23.7% | Reduced | History |
| STROSutro Biopharma, Inc. | COM | 2,191,439 | $41.4M | 2.7% | +118,564+5.7% | Added | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 441,159 | $39.8M | 2.6% | +211,913+92.4% | Added | History |
| HCATHealth Catalyst, Inc. | COM | 794,960 | $39.8M | 2.6% | +5,567+0.7% | Added | History |
| ARNAArena Pharmaceuticals Inc | COM NEW | 646,162 | $38.5M | 2.5% | +29,038+4.7% | Added | History |
| CUTRCutera Inc | COM | 768,727 | $35.8M | 2.4% | −248,796−24.5% | Reduced | History |
| AXGNAxogen, Inc. | COM | 2,239,261 | $35.4M | 2.3% | +17,588+0.8% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 1,227,283 | $33.8M | 2.2% | −158,365−11.4% | Reduced | History |
| KRTXKaruna Therapeutics, Inc. | COM | 275,644 | $33.7M | 2.2% | +864+0.3% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 633,481 | $33.1M | 2.2% | +106,831+20.3% | Added | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 732,731 | $30.5M | 2.0% | +732,731 | New | History |
| TPTXTurning Point Therapeutics, Inc. | COM | 452,878 | $30.1M | 2.0% | +57,053+14.4% | Added | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 2,985,712 | $26.2M | 1.7% | −485,747−14.0% | Reduced | History |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 204,600 | $25.7M | 1.7% | +121,931+147.5% | Added | – |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 2,623,031 | $25.5M | 1.7% | −350,061−11.8% | Reduced | History |
| LITSLite Strategy, Inc. | COM NEW | 8,637,475 | $23.8M | 1.6% | +1,641,768+23.5% | Added | History |
| AXNXAxonics, Inc. | COM | 341,825 | $22.2M | 1.5% | +8,952+2.7% | Added | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 1,774,668 | $21.6M | 1.4% | +13,857+0.8% | Added | History |
| Itamar Med Ltd465437101 | SPONSORED ADS | 662,969 | $20.0M | 1.3% | +76,549+13.1% | Added | – |
| PHLTPerformant Healthcare Inc | COM | 4,437,930 | $17.6M | 1.2% | +4,437,930 | New | History |
| YMABY-mAbs Therapeutics, Inc. | COM | 577,663 | $16.5M | 1.1% | −372,529−39.2% | Reduced | History |
| CDXSCodexis, Inc. | COM | 699,716 | $16.3M | 1.1% | −3,450−0.5% | Reduced | History |
| KRMDKORU Medical Systems, Inc. | COM | 5,408,426 | $15.4M | 1.0% | −15,921−0.3% | Reduced | History |
| KIDSOrthopediatrics Corp | COM | 232,492 | $15.2M | 1.0% | +2,616+1.1% | Added | History |
| SIBNSI-BONE, Inc. | COM | 705,682 | $15.1M | 1.0% | +1,452+0.2% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 176,559 | $13.6M | 0.9% | +176,559 | New | History |
| MXCTMaxcyte, Inc. | COM | 994,670 | $12.1M | 0.8% | +994,670 | New | History |
| GMABGenmab A/S | SPONSORED ADS | 258,991 | $11.3M | 0.7% | −348,055−57.3% | Reduced | History |
| QDELQuidelOrtho Corp | COM | 73,010 | $10.3M | 0.7% | +586+0.8% | Added | History |
| STIMNeuronetics, Inc. | COM | 1,458,818 | $9.57M | 0.6% | −5,018−0.3% | Reduced | History |
| SIENProject Sage Oldco, Inc. | COM | 1,577,762 | $9.04M | 0.6% | +1,252,410+384.9% | Added | History |
| ANNXAnnexon, Inc. | COM | 483,773 | $9.00M | 0.6% | +277,696+134.8% | Added | History |
| APTOAptose Biosciences Inc. | COM NEW | 4,128,443 | $9.00M | 0.6% | +13,032+0.3% | Added | History |
| AKUAkumin Inc. | COM | 3,559,911 | $8.83M | 0.6% | 00.0% | Unchanged | History |
| WWWW International, Inc. | COM | 458,273 | $8.36M | 0.6% | +458,273 | New | History |
| NVTAInvitae Corp | COM | 256,367 | $7.29M | 0.5% | +1,051+0.4% | Added | History |
| KROSKeros Therapeutics, Inc. | COM | 173,210 | $6.85M | 0.5% | +173,210 | New | History |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 118,703 | $5.83M | 0.4% | −83,435−41.3% | Reduced | History |
| JYNTJOINT Corp | COM | 55,525 | $5.44M | 0.4% | −61,238−52.4% | Reduced | History |
| TCRRTCR2 Therapeutics Inc. | COM | 620,887 | $5.28M | 0.3% | −23,329−3.6% | Reduced | History |
| MIROMiromatrix Medical Inc. | COM | 475,000 | $3.31M | 0.2% | 00.0% | Unchanged | History |
| SLPSimulations Plus, Inc. | COM | 75,123 | $2.97M | 0.2% | −709−0.9% | Reduced | History |
| LHCGLHC Group, Inc | COM | 15,259 | $2.39M | 0.2% | −163−1.1% | Reduced | History |
| RLAYRelay Therapeutics, Inc. | COM | 51,848 | $1.64M | 0.1% | −338,707−86.7% | Reduced | History |
| NARIInari Medical, Inc. | Stock | 11,734 | $952.0K | 0.1% | +11,734 | New | History |
| HRCHill-Rom Holdings, Inc. | COM | 4,346 | $652.0K | <0.1% | 00.0% | Unchanged | History |
| AVTRAvantor, Inc. | COM | 14,596 | $597.0K | <0.1% | 00.0% | Unchanged | History |
| WATWaters Corp | COM | 1,536 | $549.0K | <0.1% | 00.0% | Unchanged | History |
| ITGRInteger Holdings Corp | COM | 5,846 | $522.0K | <0.1% | 00.0% | Unchanged | History |
| SYNHSyneos Health, Inc. | CL A | 5,736 | $502.0K | <0.1% | 00.0% | Unchanged | History |
| NVSTEnvista Holdings Corp | COM | 11,793 | $493.0K | <0.1% | 00.0% | Unchanged | History |
| GSKGSK plc | SPONSORED ADR | 12,574 | $480.0K | <0.1% | 00.0% | Unchanged | History |
| BAXBaxter International Inc | Stock | 5,929 | $477.0K | <0.1% | 00.0% | Unchanged | History |
| ICUIIcu Medical Inc | COM | 2,039 | $476.0K | <0.1% | 00.0% | Unchanged | History |
| NUVANuvasive Inc | COM | 7,850 | $470.0K | <0.1% | 00.0% | Unchanged | History |
| CVSCVS Health Corp | Stock | 5,519 | $468.0K | <0.1% | 00.0% | Unchanged | History |
| GILDGilead Sciences, Inc. | Stock | 6,705 | $468.0K | <0.1% | 00.0% | Unchanged | History |
| PRGOPERRIGO Co plc | SHS | 9,823 | $465.0K | <0.1% | 00.0% | Unchanged | History |
| ELVElevance Health, Inc. | Stock | 1,244 | $464.0K | <0.1% | 00.0% | Unchanged | History |
| BDXBecton Dickinson & Co | Stock | 1,888 | $464.0K | <0.1% | 00.0% | Unchanged | History |
| UTHRUnited Therapeutics Corp | COM | 2,466 | $455.0K | <0.1% | 00.0% | Unchanged | History |
| HOLXHologic Inc | COM | 5,845 | $431.0K | <0.1% | 00.0% | Unchanged | History |
| BMYBristol Myers Squibb Co | Stock | 7,256 | $429.0K | <0.1% | 00.0% | Unchanged | History |
| TAKTakeda Pharmaceutical Co Ltd | ADR | 25,630 | $420.0K | <0.1% | 00.0% | Unchanged | History |
| HUMHumana Inc | Stock | 1,068 | $416.0K | <0.1% | 00.0% | Unchanged | History |
| ABBVAbbVie Inc. | Stock | 3,740 | $403.0K | <0.1% | 00.0% | Unchanged | History |
| CICigna Group | Stock | 1,943 | $389.0K | <0.1% | 00.0% | Unchanged | History |
| PFEPfizer Inc | Stock | 8,469 | $364.0K | <0.1% | 00.0% | Unchanged | History |
| JNJJohnson & Johnson | Stock | 2,161 | $349.0K | <0.1% | 00.0% | Unchanged | History |
| SNYSanofi | SPONSORED ADR | 6,650 | $321.0K | <0.1% | 00.0% | Unchanged | History |
| UHSUniversal Health Services Inc | CL B | 2,050 | $284.0K | <0.1% | 00.0% | Unchanged | History |
| MCKMcKesson Corp | Stock | 1,346 | $268.0K | <0.1% | 00.0% | Unchanged | History |
| EBSEmergent BioSolutions Inc. | COM | 4,294 | $215.0K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q2 2021 (3)
Positions held at the end of Q2 2021 that are gone from this filing.
| Security | Class | Shares in Q2 2021 | Value in Q2 2021 | % of portfolio in Q2 2021 | History |
|---|---|---|---|---|---|
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 465,572 | $38.6M | 2.3% | History |
| GKOSGLAUKOS Corp | COM | 409,144 | $34.7M | 2.1% | History |
| FATEFate Therapeutics Inc | COM | 15,400 | $1.34M | 0.1% | History |